Download PDF
Thromb Haemost 2010; 103(01): 3-6
DOI: 10.1055/s-0037-1608916
Editor’s Choice
Schattauer GmbH

Editor´s choice articles 2008–2009

Gregory Y. H. Lip
1   Haemostasis Thrombosis & Vascular Biology Unit, University of Birmingham Centre for Cardiovascular Sciences, City Hospital, Birmingham, UK
,
Klaus T. Preissner
2   Institute for Biochemistry, Justus Liebig University, Giessen, Germany
,
Christian Weber
3   Institute for Molecular Cardiovascular Research (IMCAR), RWTH Aachen University, Aachen, Germany
› Author Affiliations
Further Information

Publication History

Publication Date:
15 December 2017 (online)

Also available at
    Permissions and Reprints

 

 

  • References

  • 1 Weimer T, Wormsbächer W, Kronthaler U. et al. Prolonged in-vivo half-life of factor VIIa by fusion to albumin. Thromb Haemost 2008; 99: 659-667.
    Thieme ConnectPubMedSearch in Google Scholar
  • 2 Metzner HJ, Weimer T, Kronthaler U. et al. Genetic fusion to albumin improves the pharmacokinetic properties of factor IX. Thromb Haemost 2009; 102: 634-644.
    Thieme ConnectPubMedSearch in Google Scholar
  • 3 Hedner U. Factor VIIa and its potential therapeutic use in bleeding-associated pathologies. Thromb Haemost 2008; 100: 557-562.
    Thieme ConnectPubMedSearch in Google Scholar
  • 4 Nalian A, Lakhiaev AV. Possible mechanisms contributing to oxidative inactivation of activated protein C: Molecular dynamics study. Thromb Haemost 2008; 100: 18-25.
    Thieme ConnectPubMedSearch in Google Scholar
  • 5 Nishio M, Koyama T, Nakahara M. et al. Proteasome degradation of protein C and plasmin inhibitor mutants. Thromb Haemost 2008; 100: 405-412.
    Thieme ConnectPubMedSearch in Google Scholar
  • 6 Schuepbach RA, Feistritzer C, Fernández JA. et al. Protection of vascular barrier integrity by activated protein C in murine models depends on protease-activated receptor-1. Thromb Haemost 2009; 101: 724-733.
    Thieme ConnectPubMedSearch in Google Scholar
  • 7 Bae J-S, Rezaie AR. Thrombin inhibits nuclear factor κB and RhoA pathways in cytokine-stimulated vascular endothelial cells when EPCR is occupied by protein C. Thromb Haemost 2009; 101: 513-520.
    Thieme ConnectPubMedSearch in Google Scholar
  • 8 Grove EL, Hvas A-M, Kristensen SD. Immature platelets in patients with acute coronary syndromes. Thromb Haemost 2009; 101: 151-156.
    Thieme ConnectPubMedSearch in Google Scholar
  • 9 Busch G, Steppich B, Sibbing D. et al. Bivalirudin reduces platelet and monocyte activation after elective percutaneous coronary intervention. Thromb Haemost 2009; 101: 340-344.
    Thieme ConnectPubMedSearch in Google Scholar
  • 10 Seizer P, Borst O, Langer HF. et al. EMMPRIN (CD147) is a novel receptor for platelet GPVI and mediates platelet rolling via GPVI-EMMPRIN interaction. Thromb Haemost 2009; 101: 682-686.
    Thieme ConnectPubMedSearch in Google Scholar
  • 11 Dellas C, Schäfer K, Rohm I. et al. Absence of leptin resistance in platelets from morbidly obese individuals may contribute to the increased thrombosis risk in obesity. Thromb Haemost 2008; 100: 1123-1129.
    Thieme ConnectPubMedSearch in Google Scholar
  • 12 Zimmermann N, Hohlfeld T. Clinical implications of aspirin resistance. Thromb Haemost 2008; 100: 379-390.
    Thieme ConnectPubMedSearch in Google Scholar
  • 13 Serebruany V, Shalito I, Kopyleva O. Prasugrel development – claims and achievements. Thromb Haemost 2009; 101: 14-22.
    Thieme ConnectPubMedSearch in Google Scholar
  • 14 Distelmaier K, Adlbrecht C, Jakowitsch J. et al. Local complement activation triggers neutrophil recruitment to the site of thrombus formation in acute myocardial infarction. Thromb Haemost 2009; 102: 564-572.
    Thieme ConnectPubMedSearch in Google Scholar
  • 15 Torzewski M, Reifenberg K, Cheng F. et al. No effect of C-reactive protein on early atherosclerosis in LDLR-/- / human C-reactive protein transgenic mice. Thromb Haemost 2008; 99: 196-201.
    Thieme ConnectPubMedSearch in Google Scholar
  • 16 Schwarz M, Spath L, Lux CA. et al. Potential protective role of apoprotein J (clusterin) in atherogenesis: Binding to enzymatically modified low-density lipoprotein reduces fatty acid-mediated cytotoxicity. Thromb Haemost 2008; 100: 110-118.
    Thieme ConnectPubMedSearch in Google Scholar
  • 17 Folsom AR, Lutsey PL, Astor BC. et al. C-reactive protein and venous thromboembolism – A prospective investigation in the ARIC cohort. Thromb Haemost 2009; 102: 615-619.
    Thieme ConnectPubMedSearch in Google Scholar
  • 18 Di Santo S, Tepper OM, von Ballmoos MW. et al. Cell-based therapy facilitates venous thrombus resolution. Thromb Haemost 2009; 101: 460-464.
    Thieme ConnectPubMedSearch in Google Scholar
  • 19 Feng Y, vom Hagen F, Wang Y. et al. The absence of angiopoietin-2 leads to abnormal vascular maturation and persistent proliferative retinopathy. Thromb Haemost 2009; 102: 120-130.
    Thieme ConnectPubMedSearch in Google Scholar
  • 20 Strijbos MH, Verhoef C, Gratama JW. et al. On the origin of (CD105+) circulating endothelial cells. Thromb Haemost 2009; 102: 347-351.
    Thieme ConnectPubMedSearch in Google Scholar
  • 21 Diehl P, Nagy F, Sossong V. et al. Increased levels of circulating microparticles in patients with severe aortic valve stenosis. Thromb Haemost 2008; 99: 711-719.
    Thieme ConnectPubMedSearch in Google Scholar
  • 22 Ray DM, Spinelli SL, Pollock SJ. et al. Peroxisome proliferator-activated receptor ? and retinoid X receptor transcription factors are released from activated human platelets and shed in microparticles. Thromb Haemost 2008; 99: 86-95.
    Thieme ConnectPubMedSearch in Google Scholar
  • 23 Brouckova A, Holada K. Cellular prion protein in blood platelets associates with both lipid rafts and the cytoskeleton. Thromb Haemost 2009; 102: 966-974.
    Thieme ConnectPubMedSearch in Google Scholar
  • 24 Lip GY. Paroxysmal atrial fibrillation, stroke risk and thromboprophylaxis. Thromb Haemost 2008; 100: 11-13.
    Thieme ConnectPubMedSearch in Google Scholar
  • 25 Hughes M, Lip GY. Guideline Development Group, National Clinical Guideline for Management of Atrial Fibrillation in Primary and Secondary Care, National Institute for Health and Clinical Excellence. Stroke and thromboembolism in atrial fibrillation: a systematic review of stroke risk factors, risk stratification schema and cost effectiveness data. Thromb Haemost 2008; 99: 295-304.
    Thieme ConnectPubMedSearch in Google Scholar
  • 26 Poli D, Antonucci E, Grifoni E. et al. Stroke risk in atrial fibrillation patients on warfarin. Predictive ability of risk stratification schemes for primary and secondary prevention. Thromb Haemost 2009; 101: 367-372.
    Thieme ConnectPubMedSearch in Google Scholar
  • 27 Rallidis LS, Politou M, Komporozos C. et al. Factor XIII Val34Leu polymorphism and the risk of myocardial infarction under the age of 36 years. Thromb Haemost 2008; 99: 1085-1089.
    Thieme ConnectPubMedSearch in Google Scholar
  • 28 Ay C, Jungbauer LV, Kaider A. et al. P-selectin gene haplotypes modulate soluble P-selectin concentrations and contribute to the risk of venous thromboembolism. Thromb Haemost 2008; 99: 899-904.
    Thieme ConnectPubMedSearch in Google Scholar
  • 29 Levine RL, LeClerc JR, Bailey JE. et al. Venous and arterial thromboembolism in severe sepsis. Thromb Haemost 2008; 99: 892-898.
    Thieme ConnectPubMedSearch in Google Scholar
  • 30 Schreijer AJ, Cannegieter SC, Caramella M. et al. Fluid loss does not explain coagulation activation during air travel. Thromb Haemost 2008; 99: 1053-1059.
    Thieme ConnectPubMedSearch in Google Scholar
  • 31 Meckley LM, Wittkowsky AK, Rieder MJ. et al. An analysis of the relative effects of VKORC1 and CYP2C9 variants on anticoagulation related outcomes in warfarin-treated patients. Thromb Haemost 2008; 100: 229-239.
    Thieme ConnectPubMedSearch in Google Scholar
  • 32 Palareti G, Cosmi B. Bleeding with anticoagulation therapy – who is at risk, and how best to identify such patients. Thromb Haemost 2009; 102: 268-278.
    Thieme ConnectPubMedSearch in Google Scholar
  • 33 Trujillo-Santos J, Nieto JA, Tiberio G. et al. Predicting recurrences or major bleeding in cancer patients with venous thromboembolism. Findings from the RIETE Registry. Thromb Haemost 2008; 100: 435-439.
    Thieme ConnectPubMedSearch in Google Scholar